One additional skin lightening or whitening quasi-drug (QD) has been developed and officially approved by the Ministry of Health, Labor and Welfare of Japan. The active ingredient niacinamide should be included in this review \[[@b1-ijms-11-02699]\]. Its mechanism of skin lightening is based on the inhibition of melanosome transfer from melanocytes to keratinocytes. Niacinamide is listed in [Table 1](#t1-ijms-11-02699){ref-type="table"}, which classifies compounds according to the mechanism of skin lightening QDs registered in Japan.

2.15.. Niacinamide (Obtained by Procter & Gamble Company in 2007)
=================================================================

Niacinamide (also termed nicotinamide), a derivative of vitamin B~3~, has been shown to act as an anti-inflammatory agent in acne \[[@b2-ijms-11-02699]\]. Niacinamide had no effect on the tyrosinase activity and melanin synthesis of cultured normal human melanocytes, however, it was found that niacinamide significantly decreased hyperpigmentation, such as melasma and solar lentigines, via inhibition of melanosome transfer from melanocytes to keratinocytes \[[@b3-ijms-11-02699],[@b4-ijms-11-02699]\].

###### 

Mechanistic classification of skin lightening QDs approved by the MHLW of Japan.

  ***Target***                      ***Mechanism***                        ***Detail***                       ***Skin Lightening QD***
  --------------------------------- -------------------------------------- ---------------------------------- -----------------------------------------------
  **Melanocyte**                    Inhibition of tyrosinase activity      Anti-oxidation                     Ascorbic acid/derivatives
                                                                                                              
  Chelating copper atoms            Kojic acid                             Ellagic acid                       
                                                                                                              
  Competitive inhibition            Arbutin 4MSK                           Rucinol® 4-HPB                     
                                                                                                              
                                    Decrease of tyrosinase protein level   Acceleration of Tyr degradation    Linoleic acid
                                                                                                              
  Inhibition of Tyr maturation      Magnolignan®                                                              
                                                                                                              
  **Keratinocyte**                  Inhibition of KC-MC signaling          Inhibition of UV inflammation      Chamomilla extract Tranexamic acid/derivative
                                                                                                              
  **Melanocyte and Keratinocyte**   Inhibition of melanosome transfer      Inhibition of melanin dispersion   Niacinamide
                                                                                                              
  **Epidermis**                     Acceleration of epidermal turnover     Desquamation of melanin            Placental extract Adenosine mono-phosphate

KC: keratinocyte; MC: melanocyte; Tyr: tyrosinase; UV: ultraviolet light.
